A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain

Detalhes bibliográficos
Autor(a) principal: Cioato, Stefania Giotti
Data de Publicação: 2022
Outros Autores: Medeiros, Liciane Fernandes, Lopes, Bettega Costa, Medeiros, Helouise Richardt, Caumo, Wolnei, Roesler, Rafael, Torres, Iraci LS
Tipo de documento: Artigo
Idioma: por
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/116706
Resumo: Introduction: Considering the lack of specific treatments to neuropathic pain, this study aimed to evaluate the effect of a single dose adenosine A3 receptor IB-MECA in the inflammatory and neurotrophic parameters of rats submitted to a neuropathic pain model. Methods: 64 adults male Wistar rats were used.  Neuropathic pain was induced by the chronic constriction injury (CCI) of sciatic nerve and the treatment consisted in one dose of 0.5 μmol/kg of a selective agonist of adenosine A3 receptor IB-MECA dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline; morphine groups received 5mg/kg Cerebral cortex and hippocampus IL-1β, BDNF and NGF levels were determined by ELISA assay. Results: The key finding was that a single dose of IB-MECA was able to modulate the IL-1β hippocampus levels CCI and the DMSO increased IL-1β and NGF hippocampus levels in sham animals; however, when the DMSO as an IB-MECA vehicle, this effect was not observed, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain is quite explored, as well as the hippocampus contributions, our result corroborates the relationship of A3 receptor and the chronic pain maintenance process. @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes;}div.WordSection1 {page:WordSection1;}
id UFRGS-20_d6369c2c4fb5001d0db4bd97f54db6bc
oai_identifier_str oai:seer.ufrgs.br:article/116706
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic painadenosine A3 receptorcytokineDMSOIB-MECAneuropathic painneurotrophinrats.Introduction: Considering the lack of specific treatments to neuropathic pain, this study aimed to evaluate the effect of a single dose adenosine A3 receptor IB-MECA in the inflammatory and neurotrophic parameters of rats submitted to a neuropathic pain model. Methods: 64 adults male Wistar rats were used.  Neuropathic pain was induced by the chronic constriction injury (CCI) of sciatic nerve and the treatment consisted in one dose of 0.5 μmol/kg of a selective agonist of adenosine A3 receptor IB-MECA dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline; morphine groups received 5mg/kg Cerebral cortex and hippocampus IL-1β, BDNF and NGF levels were determined by ELISA assay. Results: The key finding was that a single dose of IB-MECA was able to modulate the IL-1β hippocampus levels CCI and the DMSO increased IL-1β and NGF hippocampus levels in sham animals; however, when the DMSO as an IB-MECA vehicle, this effect was not observed, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain is quite explored, as well as the hippocampus contributions, our result corroborates the relationship of A3 receptor and the chronic pain maintenance process. @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes;}div.WordSection1 {page:WordSection1;}HCPA/FAMED/UFRGS2022-07-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed ArticleAvaliado por Paresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/116706Clinical & Biomedical Research; Vol. 42 No. 2 (2022): Clinical & Biomedical ResearchClinical and Biomedical Research; v. 42 n. 2 (2022): Clinical and Biomedical Research2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/116706/85500Copyright (c) 2022 Clinical and Biomedical Researchhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCioato, Stefania GiottiMedeiros, Liciane FernandesLopes, Bettega CostaMedeiros, Helouise RichardtCaumo, WolneiRoesler, RafaelTorres, Iraci LS2024-01-19T14:12:37Zoai:seer.ufrgs.br:article/116706Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2024-01-19T14:12:37Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
spellingShingle A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
Cioato, Stefania Giotti
adenosine A3 receptor
cytokine
DMSO
IB-MECA
neuropathic pain
neurotrophin
rats.
title_short A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_full A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_fullStr A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_full_unstemmed A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_sort A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
author Cioato, Stefania Giotti
author_facet Cioato, Stefania Giotti
Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci LS
author_role author
author2 Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci LS
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cioato, Stefania Giotti
Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci LS
dc.subject.por.fl_str_mv adenosine A3 receptor
cytokine
DMSO
IB-MECA
neuropathic pain
neurotrophin
rats.
topic adenosine A3 receptor
cytokine
DMSO
IB-MECA
neuropathic pain
neurotrophin
rats.
description Introduction: Considering the lack of specific treatments to neuropathic pain, this study aimed to evaluate the effect of a single dose adenosine A3 receptor IB-MECA in the inflammatory and neurotrophic parameters of rats submitted to a neuropathic pain model. Methods: 64 adults male Wistar rats were used.  Neuropathic pain was induced by the chronic constriction injury (CCI) of sciatic nerve and the treatment consisted in one dose of 0.5 μmol/kg of a selective agonist of adenosine A3 receptor IB-MECA dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline; morphine groups received 5mg/kg Cerebral cortex and hippocampus IL-1β, BDNF and NGF levels were determined by ELISA assay. Results: The key finding was that a single dose of IB-MECA was able to modulate the IL-1β hippocampus levels CCI and the DMSO increased IL-1β and NGF hippocampus levels in sham animals; however, when the DMSO as an IB-MECA vehicle, this effect was not observed, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain is quite explored, as well as the hippocampus contributions, our result corroborates the relationship of A3 receptor and the chronic pain maintenance process. @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes;}div.WordSection1 {page:WordSection1;}
publishDate 2022
dc.date.none.fl_str_mv 2022-07-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed Article
Avaliado por Pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/116706
url https://seer.ufrgs.br/index.php/hcpa/article/view/116706
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/116706/85500
dc.rights.driver.fl_str_mv Copyright (c) 2022 Clinical and Biomedical Research
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Clinical and Biomedical Research
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 42 No. 2 (2022): Clinical & Biomedical Research
Clinical and Biomedical Research; v. 42 n. 2 (2022): Clinical and Biomedical Research
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1799767056295395328